New Leukemia Drug Tops the Charts With a $178,... - CLL Support
New Leukemia Drug Tops the Charts With a $178,000 U.S. Price Tag
You need to be a member of this community to see this post.
Read more about...
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
The price of Imbruvica to go down for U.S. seniors in 2026!
News piece about it. Imbruvica is one of the ten drugs on the lists for negotiations!...
Interpretation of blood test
CD19+/CD20+B-cells are 56 % of total cells (absolute 12.3x10 CD
#CD 3+T-cells are 11 % of total...
An Early Look at When CAR-T Therapy Fails Patients With CLL
characteristics of patients with CLL who received anti-CD19 CAR-T therapy during a clinical trial...
A New Era is Coming up in the Treatment of Chronic Lymphocytic Leukemia
leading to the development of new agents targeting cell surface, intracellular pathways, and tumor...
flow cytometry is showing about 74% CLL involvement.
addition, it expresses CD5 and CD23, but does not express CD10. <1% of the abnormal cells express...
Car-T TV special. National Geographic break through series. 
NICE u turn after Roche drug price negotiations
Diptheria Immunotoxin Effectively Targets B-Cell Malignancies - Phase 1 trial of DT2219
Good news 4 months post CAR-T therapy
A new kid on the block? Nemtabrutinib
